Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ADMA Biologics Inc - Common Stock (NQ: ADMA ) 17.89 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 11 Open 17.89 Bid (Size) 17.65 (5) Ask (Size) 17.92 (1) Prev. Close 17.89 Today's Range 17.89 - 17.89 52wk Range 4.360 - 23.64 Shares Outstanding 196,357,149 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility December 20, 2024 From ADMA Biologics, Inc. Via GlobeNewswire ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm December 13, 2024 Via ACCESSWIRE Performance YTD +293.19% +293.19% 1 Month -18.01% -18.01% 3 Month -7.97% -7.97% 6 Month +63.38% +63.38% 1 Year +298.44% +298.44% More News Read More The Schall Law Firm Invites Shareholder Participation In An Inquiry Into ADMA Biologics Inc For Securities Law Violations December 12, 2024 Via ACCESSWIRE NewAmsterdam Pharma Stock Hits 90-Plus RS Rating December 11, 2024 Via Investor's Business Daily Looking Into ADMA Biologics's Recent Short Interest December 05, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session December 02, 2024 Via Benzinga (ADMA) - Analyzing ADMA Biologics's Short Interest October 22, 2024 Via Benzinga BioNTech Stock Got A IBD RS Rating Lift November 14, 2024 Via Investor's Business Daily ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm November 12, 2024 From Bragar Eagel & Squire Via GlobeNewswire While growth is established for NASDAQ:ADMA, the stock's valuation remains reasonable. November 12, 2024 Via Chartmill Vericel Stock Sees RS Rating Shoot Higher November 11, 2024 Via Investor's Business Daily Kirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder Investigation November 09, 2024 From Kirby McInerney LLP Via Business Wire ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update November 07, 2024 From ADMA Biologics, Inc. Via GlobeNewswire Kirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA) November 05, 2024 From Kirby McInerney LLP Via Business Wire ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm November 05, 2024 From The Schall Law Firm Via Business Wire Buckle Up And Use Volitility To Your Advantage November 03, 2024 Via Talk Markets What You Missed On Wall Street This Past Friday November 03, 2024 Via Talk Markets Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday November 01, 2024 Via Benzinga ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle November 01, 2024 Via Investor's Business Daily ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024 October 29, 2024 From ADMA Biologics, Inc. Via GlobeNewswire ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm October 29, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm October 28, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Bragar Eagel & Squire, P.C. Is Investigating ADMA Biologics, Napco, and L&W and Encourages Investors to Contact the Firm October 21, 2024 From Bragar Eagel & Squire Via GlobeNewswire ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm October 15, 2024 From Bragar Eagel & Squire Via GlobeNewswire Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade October 15, 2024 Via Investor's Business Daily Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
